U.S. health authorities approved updated versions of Pfizer and Moderna’s Covid-19 vaccines on Thursday, with the companies announcing that the shots will be available “in the coming days.”
EKO HOT BLOG gathered that the new vaccines, designed using the KP.2 variant, aim to target currently circulating variants and offer better protection against severe outcomes like hospitalization or death, according to the U.S. Food and Drug Administration (FDA).
EDITOR’S PICKS
- Midnight Fire Destroys Multi-Million Naira Goods in Anambra Market
- Poland Tightens Student Visa Rules Amid Scandal Over System Abuse
- FG Mandates Submission of Matriculation Lists to Combat Fake Degrees
“We strongly encourage those eligible to consider receiving an updated Covid-19 vaccine,” said Peter Marks, a senior FDA official, in a statement.
The vaccines will be available for individuals six months and older, with booster doses recommended at least two months after the previous shot.
The FDA’s approval comes as Covid cases have been increasing in the U.S. during the summer, ahead of the winter epidemic season.
Pfizer and Moderna both confirmed that their vaccines will be available in pharmacies, hospitals, and clinics “in the coming days.”
FURTHER READING
- Tinubu Approves Reconstruction Of Wagga Bridge Linking Adamawa, Borno
- Police Name Suspect Behind Hotel Presidential Dynamite Blast
- Mother, Five Children Die After Eating Local Delicacy In Kano
“In the 2023-24 season, we saw over 600,000 Covid-related hospitalizations in the U.S.,” said Moderna CEO Stephane Bancel. “Staying up to date with your Covid-19 vaccine remains one of the best ways to protect against severe illness.”
Despite efforts to promote annual Covid vaccinations similar to the flu shot, only 22.5% of adults and 14% of children have received an updated vaccine dose for the 2023-2024 season, according to data from the Centers for Disease Control and Prevention (CDC).
Click here to watch our video of the week:
Advertise or Publish a Story on EkoHot Blog:
Kindly contact us at [email protected]. Breaking stories should be sent to the above email and substantiated with pictorial evidence.
Citizen journalists will receive a token as data incentive.
Call or Whatsapp: 0803 561 7233, 0703 414 5611
